 |
Bioterrorism
and Vaccine Update
|
 |

Bioterrorism: A New
Challenge for the Allergist
Daniel Rotrosen, MD, Director,
Div. of All/Imm and Transplantation, NIAID
|
 |
Update
on Vaccines for the Allergist: The
Good
Joseph
A. Bellanti, MD
|
 |
Update
on Vaccines for the Allergist: The
Bad
Renata
J.M. Engler, MD
|
 |
Update
on Vaccines for the Allergist: The
Ugly
Theodore
M. Freeman, MD
|
 |
Emerging Therapies |
 |
 Overview of Immunomodulatory
Strategies
Thomas B. Casale,
MD
|
 |
Alpha
and Omega of Therapeutic Approaches: Oral Immunotherapy and PDE4 Antagonists
John
J. Condemi, MD
|
 |
Ethical Issues in Clinical Research |
 |
Why Do A Placebo-Controlled
Trial
Mark S. Dykewicz,
MD
|
 |
Ethics of Placebo-Controlled
Studies
Jonathan
Moreno, PhD
|
 |
Environmental Molds |
 |
 Biology of Molds
Elliott Horner,
PhD
|
 |
Home Assessments:
How They Are Done
Joseph Fedoruk
|
 |
Jean
A. Chapman Lecture
Health Effects of Mold Exposure and How to Evaluate
Patients Who Think They Have It 
Emil
J. Bardana, Jr., MD
|
 |
Mold in Schools
John Santilli,
MD
|
 |
Legal Aspects
of Mold
Court Purdy,
JD
|
 |
Controversies in Sinusitis |
 |
 John McGovern Lecture
Hyperplastic Sinusitis: Atopic Inflammation and
Its Appropriate Management
Supported by an educational grant from the John P. McGovern Foundation
Larry Borish,
MD
|
 |
Bernard
Berman Memorial Lecture
Allergic Fungal Sinusitis

Richard D. deShazo,
MD
|
 |
Management of Sinus
Headache: Is it a Migraine Variant?
Stewart Tepper, MD
|
 |
Question and Answer Session
Panel
|
 |
Evaluation and Management of Acute Severe Asthma |
 |

Assessment
of Severity of Acute Asthma
Bradley
E, Chipps, MD
|
 |
Bronchodilatory
Therapy: Delivery Systems and Dosing Strategies
John
J. Oppenheimer, MD
|
 |
Corticosteroid:
Oral, Parenteral, Inhaled
Christopher
G. Fanta, MD
|
 |
Alternative
Treatment Strategies: LTRA, MGS04, He/O2, non-invasive vent
Thomas
Corbridge, MD
|
 |
Urticaria: Its Pathophysiology and Management |
 |
 Daniel Goodman Lecture
Autoimmune Issues in Urticaria
Allen P. Kaplan,
MD
|
 |
Urticarial Vasculitic
Syndromes
Albert F. Finn,
Jr., MD
|
 |
Difficult to Manage
Urticaria Patient
Roger W. Fox,
MD
|
 |
Question and Answer Session
Panel
|
 |
Rheumatology for the Allergist |
 |
 Rheumatologic Disorders
Masquerading as Allergic Diseases
Marianne Frieri,
MD, PhD
|
 |
Diagnostic Utility
of Antinuclear and Anticytoplasmic Antibodies for the Non Rheumatologist
John J. Condemi,
MD
|
 |
Are Silicone Breast
Implants Associated with Autoimmunity?
Henry N. Claman,
MD
|
 |
Question and Answer Session
Panel
|
 |
JCAAI Session |
 |
 Remodeling Our
National System for Protection of Human Subjects in Research
Debra
R. Lappin, JD
|
 |
Question and Answer Session
Panel
|
 |
Stanislaus Jaros Lecture |
 |

Atopic Dermatitis - Is It
Skin Allergy?
Donald
Y.M. Leung, MD
|
 |
Annual Business Meeting |
 |

Annual
Business Meeting
Bobby
Q. Lanier, MD, Presiding
|
 |
The Road to Improvement: Oral Immunotherapy – An Alternative
to Conventional Immunotherapy |
 |

Bela Schick
Lecture
Allergy Training Programs – Are the Golden
Days Over?

Richard W. Weber,
MD
|
 |
Oral
and Sublingual Immunotherapy – Italian Experience
Giorgio W. Canonica, MD
|
 |
Oral Immunotherapy
– American Experience
Dale
T. Umetsu, MD
|
 |
The Case for Sublingual
Immunotherapy – European and Swiss Experience
Martin
K. Kägi, MD
|
 |
The Case Against
Oral Immunotherapy
Jay
M. Portnoy, MD
|
 |
Legal and Ethical
Implications of Using Methods of Immunotherapy Not FDA Approved
Richard
Verville, JD
|
 |
Question and Answer Session
Panel
|
 |
Anaphylaxis |
 |
 Mechanisms of Anaphylaxis
Richard W. Weber,
MD
|
 |
Anaphylaxis in
the Office – Allergists Be Prepared
Dana
V. Wallace, MD
|
 |
Are We Prepared?
Where Do We Stand?
|
 |
Immunologic Skin Disease
|
 |
 Autoimmune Blistering
Skin Diseases
Grant J. Anhalt, MD
|
 |
Contact
Dermatitis: the Eyelids as a Paradigm
Jere
Guin, MD
|
 |
Pathophysiology
of Atopic Dermatitis
Ernest
N. Charlesworth, MD
|
 |
Questions
and Answer Session
Panel
|
<